Honestly.. let’s just hope all the money the company sells is accounted for? I mean.. we all know $45-$50k a quarter with no PRs and basically one quarter pays for an accountant and filings for a year..
You obviously don't understand how tough/impossible it is to get conventional funding while trading in pennyland in the last 2-3 years, let alone trading in the "tenths of a penny" range. Only way this company gets conventional funding for trials IMO is IF the toxicity report is approved from the FDA.
News 
Market Data 
Discover 
AI
